Oncopeptides AB (publ) (ONCO) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Oncopeptides Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.637 Welcome to Oncopeptide's third quarter earnings call for 2025. 00:00:03.637 -- 00:00:09.106 For the first part of the conference call, the participants will be in listen-only mode. 00:00:09.106 -- 00:00:13.753 During the questions and answers session, participants are able to ask questions by dialing 00:00:13.753 -- 00:00:19.022 pound key 5 on their telephone keypad. Now I will hand the conference over to CEO 00:00:19.022 -- 00:00:24.652 Sophia Hagas and CFO Henrik Bergentoft. Please go ahead. 00:00:24.652 -- 00:00:29.980 Hi everyone and welcome to the presentation of Oncopeptides report for the third quarter 00:00:29.980 -- 00:00:31.742 of 2025. 00:00:31.742 -- 00:00:36.069 My name is Sofia Heggis and I am the CEO of Oncopeptides. 00:00:36.069 -- 00:00:41.116 As we have increased our shareholder base the last quarter I wish to welcome old as well 00:00:41.116 -- 00:00:44.481 as new shareholders to this earnings course. 00:00:44.481 -- 00:00:47.225 This is our standard disclaimer. 00:00:47.225 -- 00:00:52.914 As usually I'm joined by our CFO Henrik Bergentoft and together we present our financial 00:00:52.914 -- 00:00:58.045 and operational performance for the third quarter, which is concluding that we are still 00:00:58.045 -- 00:01:03.131 on track towards becoming a profitable company by the end of 2026. 00:01:03.456 -- 00:01:08.426 The third quarter was a strategically important period for local peptides, as we knew 00:01:08.426 -- 00:01:13.796 we would have to demonstrate resilience in execution given the vacation period. 00:01:13.796 -- 00:01:19.911 Net sales reached 20.2 million sets representing a 174% increase 00:01:19.911 -- 00:01:25.163 year over year and marking our fourth consecutive quarter over quarter 00:01:25.163 --...